Skip to main content
Journal cover image

Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial

Publication ,  Conference
Pol, T; Hijazi, Z; Alexander, JH; Alings, M; Erol, C; Granger, CB; Goto, S; Halvorsen, S; Held, C; Huber, K; Hanna, M; Lopes, RD; Ruzyllo, W ...
Published in: EUROPEAN HEART JOURNAL
August 1, 2017

Duke Scholars

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

August 1, 2017

Volume

38

Start / End Page

760 / 761

Publisher

OXFORD UNIV PRESS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pol, T., Hijazi, Z., Alexander, J. H., Alings, M., Erol, C., Granger, C. B., … Wallentin, L. (2017). Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL (Vol. 38, pp. 760–761). OXFORD UNIV PRESS.
Pol, T., Z. Hijazi, J. H. Alexander, M. Alings, C. Erol, C. B. Granger, S. Goto, et al. “Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial.” In EUROPEAN HEART JOURNAL, 38:760–61. OXFORD UNIV PRESS, 2017.
Pol T, Hijazi Z, Alexander JH, Alings M, Erol C, Granger CB, et al. Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2017. p. 760–1.
Pol T, Hijazi Z, Alexander JH, Alings M, Erol C, Granger CB, Goto S, Halvorsen S, Held C, Huber K, Hanna M, Lopes RD, Ruzyllo W, Siegbahn A, Wallentin L. Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2017. p. 760–761.
Journal cover image

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

August 1, 2017

Volume

38

Start / End Page

760 / 761

Publisher

OXFORD UNIV PRESS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology